Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tensha Therapeutics Inc.

Division of Roche
www.tenshatherapeutics.com

Latest From Tensha Therapeutics Inc.

Novartis' Drug Discovery Head Jay Bradner On What NIBR Is Investing In

NIBR's Bradner talked to Scrip about how AveXis turbo-charged Novartis' gene therapy development, investing in inflammasome research, and partnering nimbly like a venture capitalist.

Leadership Research and Development Strategies

Biopharma Quarterly Dealmaking Statistics, Q1 2016

Q1 biopharma financing totaled $5.7 billion, a sharp drop from Q4, but this time early-stage venture rounds were the most popular fundraising vehicle;Q1 M&A also declined, totaling $12.3 billion, mostly from Mylan's $9.9 billion buy of Meda. The top alliance was again by Sanofi, in a five-year potential $2.26 billion collaboration with DiCE Molecules to develop oral small-molecule therapies against up to 12 targets.

BioPharmaceutical Deals

Deals In Depth: January 2016

Nestle Health signed a $1.9 billion microbiome deal with Seres; Thermo Fisher paid $1.3 billion for fellow life sciences company Affymetrix. Biopharma and device financing totaled $2.9 billion and $254 million, respectively.

BioPharmaceutical Medical Device

IN VIVO’s Deals Of The Month: January 2016

IN VIVO’s editors pick January's top alliance, financing and M&A deals (free with registration).

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Roche
  • Senior Management
  • Douglas E Onsi, CEO
    James Bradner, MD, Scientific Founder
    Steven Landau, MD, CMO
  • Contact Info
  • Tensha Therapeutics Inc.
    Phone: (617) 252-4343
    55 Cambridge Pkwy.
    Ste. 102
    Cambridge, MA 02142
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register